Phase 2, 3 of Clinical trials for children of age 2-18 for Bharat Biotech’s Covaxin vaccine cleared
For the first time in India, the Phase 2 and 3 of clinical trials for children from 2-18 age group...
Read MorePosted by Shiksha News | May 13, 2021 | News
For the first time in India, the Phase 2 and 3 of clinical trials for children from 2-18 age group...
Read MorePosted by Shiksha News | Apr 26, 2021 | News
As India nears the third phase of its inoculation drive, the Delhi CM Arvind Kejriwal announced...
Read MorePosted by Shiksha News | Apr 16, 2021 | News
In a recent development, Mumbai is no more the worst-hit COVID-19 city in India. Delhi reported...
Read MorePosted by Shiksha News | Apr 8, 2021 | News
In India, the government allowed public as well as private workplaces to inoculate the COVID-19...
Read MorePosted by Shiksha News | Apr 7, 2021 | News
In a worrying development Maharashtra sent a SOS, claiming that it has vaccine stocks only for 3...
Read MorePosted by Shiksha News | Mar 22, 2021 | News
Amid rising cases and the possibility of another nationwide lockdown we have a new COVID-19...
Read More